Ozempic and Truvada drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ozempic (semaglutide) and Truvada (emtricitabine; tenofovir disoproxil fumarate). Common drug interactions include emotional distress among females and anhedonia among males.

The phase IV clinical study analyzes what interactions people have when they take Ozempic and Truvada. It is created by eHealthMe based on reports of 30 people who take the same drugs from the FDA, and is updated regularly.

What is Ozempic?

Ozempic has active ingredients of semaglutide. It is often used in weight loss. eHealthMe is studying from 29,762 Ozempic users. Check the latest studies of Ozempic.

What is Truvada?

Truvada has active ingredients of emtricitabine; tenofovir disoproxil fumarate. It is often used in hiv infection. eHealthMe is studying from 76,246 Truvada users. Check the latest studies of Truvada.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 03, 2026

30 people who take Ozempic and Truvada together, and have interactions are studied.

Ozempic and Truvada drug interactions.

What are the common drug interactions of Ozempic and Truvada, by gender? *:

female:

  1. Emotional distress
  2. Pain
  3. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  4. Chronic kidney disease
  5. Osteoporosis (bones weak and more likely to break)
  6. Anxiety
  7. Bone density decreased
  8. Renal impairment (severely reduced kidney function)
  9. Depression
  10. Renal failure (kidney dysfunction)

male:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Foot fracture
  4. Neoplasm malignant (cancer tumour)
  5. Plasma cell myeloma (cancer that begins in plasma cells)
  6. Proteinuria (presence of protein in the urine)
  7. Spinal fracture (fracture in one of vertebrae)
  8. Dyspnoea (difficult or laboured respiration)
  9. Dysuria (painful or difficult urination)
  10. Fatigue (feeling of tiredness)

What are the common drug interactions of Ozempic and Truvada, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Chronic kidney disease
  4. Emotional distress
  5. Pain
  6. Bone density decreased
  7. Bone pain
  8. Chest pain
  9. Drug resistance (reduction in effectiveness of a drug)
  10. Fanconi syndrome acquired (self developed genetic disease of kidney damage due to defective transport system)

50-59:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Emotional distress
  4. Pain
  5. Osteoporosis (bones weak and more likely to break)
  6. Chronic kidney disease
  7. Osteopenia (a condition where bone mineral density is lower than normal)
  8. Bone density decreased
  9. Fatigue (feeling of tiredness)
  10. Gait disturbance

60+:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Hyperparathyroidism (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium)
  4. Hypokalaemia (low potassium)
  5. Osteopenia (a condition where bone mineral density is lower than normal)
  6. Proteinuria (presence of protein in the urine)
  7. Renal impairment (severely reduced kidney function)
  8. Hand fracture
  9. Joint injury
  10. Ageusia (loss of taste functions of the tongue)

What are the existing conditions these people have? *

  1. Diabetes: 3 people, 10.00%
  2. Urinary Retention (the inability to completely or partially empty the bladder): 2 people, 6.67%
  3. Type 2 Diabetes: 2 people, 6.67%
  4. Prostatomegaly (enlargement of the prostate): 2 people, 6.67%
  5. Hypovitaminosis (any of several diseases caused by deficiency of one or more vitamins): 2 people, 6.67%
  6. High Blood Pressure: 2 people, 6.67%
  7. High Blood Cholesterol: 2 people, 6.67%
  8. Heart Attack: 2 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Ozempic and Truvada?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ozempic and Truvada:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ozempic:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Truvada:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ozempic and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Truvada and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on semaglutide and emtricitabine; tenofovir disoproxil fumarate (the active ingredients of Ozempic and Truvada, respectively), and Ozempic and Truvada (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: